Nitroglycerin: Indications, Dosing, and Contraindications
Nitroglycerin is indicated for acute chest pain relief, prophylaxis of exertional angina, and management of hypertensive acute heart failure, with specific dosing and critical contraindications that must be strictly observed to prevent life-threatening hypotension.
Indications
Acute Coronary Syndromes (ACS)
- Ongoing ischemic chest pain unrelieved by initial measures 1, 2
- Hypertensive ACS with systolic blood pressure (SBP) ≥160 mmHg 1
- Pulmonary congestion/edema complicating acute MI 1, 3
Chronic Stable Angina
- Acute relief of anginal attacks 4
- Prophylaxis 5-10 minutes before activities that may precipitate angina 4, 5
Heart Failure
- Hypertensive acute heart failure with SBP ≥160 mmHg or mean arterial pressure ≥120 mmHg 6, 7
- Severe decompensated heart failure with pulmonary edema 8
Dosing Recommendations
Sublingual Administration (Acute Relief)
For acute chest pain: 0.3-0.4 mg sublingual every 5 minutes up to 3 doses 1, 2, 4
Critical instruction for patients: Take 1 dose at onset of chest pain. If pain is unimproved or worsening after 5 minutes, call 9-1-1 immediately before taking additional doses 9, 10. This represents a change from older "take 3 doses then call" protocols and prioritizes earlier activation of emergency services.
For prophylaxis: 0.3-0.4 mg sublingual 5-10 minutes before exertion 4, 5
Intravenous Administration
Initial dosing: Start at 10 mcg/min and titrate upward to desired blood pressure effect and symptom relief 1, 2
High-dose protocols for hypertensive heart failure:
- Initial bolus of 2 mg IV may be given 7
- Repeated boluses every 3 minutes up to 10 doses have been studied 7
- Mean effective doses of 6.5 mg (±3.4 mg) have been reported 7
- High-dose nitroglycerin (>100 mcg/min) shows promise in severe decompensated heart failure with lower intubation rates (13.8% vs 26.7%) and ICU admissions (37.9% vs 80.0%) compared to standard therapy 7
Important note: Tachyphylaxis may develop after approximately 24 hours of continuous infusion 2
Absolute Contraindications
These are non-negotiable and must be strictly observed:
Hypotension: SBP <90 mmHg or ≥30 mmHg below baseline 1, 3, 11
Phosphodiesterase-5 (PDE5) inhibitor use:
Right ventricular (RV) infarction (suspected or confirmed) 1, 3, 11
- RV infarction should be suspected in inferior MI with hypotension
- Right-sided ECG should be obtained if RV involvement is suspected
Tachycardia (>100 bpm in absence of heart failure) 1, 3, 11
- However, recent evidence suggests tachycardia may not be an absolute contraindication in all cases 12. While tachycardic patients (HR >100) had increased relative risk of hypotension (AOR 1.60), the absolute risk remained low (3.9% vs 2.9%). Pre-nitroglycerin blood pressure is a stronger predictor of post-administration hypotension than heart rate 12
Relative Contraindications and Cautions
- Hypertrophic cardiomyopathy: May worsen outflow obstruction 4
- Volume depletion: Use cautiously 4
- Severe aortic stenosis: Use with extreme caution
- Increased intracranial pressure: Nitroglycerin may worsen this condition
Clinical Pearls and Pitfalls
Common Pitfalls to Avoid:
- Never rely on sublingual burning sensation to assess tablet potency 4
- Do not use immediate-release dihydropyridine calcium channel blockers with nitrates without beta-blockers (Class III recommendation) 13
- Avoid excessive dosing that leads to severe headaches and tolerance 4
- Do not withhold beta-blockers to give nitrates—beta-blockers have more powerful mortality benefits 3
Administration Technique:
- Patient should sit or lie down during administration to prevent falls from orthostatic hypotension 4
- Keep tablets in original glass container with cap tightly closed 4
- Discard cotton once bottle is opened 4
Drug Interactions:
- Aspirin may enhance nitroglycerin's hemodynamic effects 4
- Alcohol potentiates hypotensive effects 4
- Calcium channel blockers may cause marked orthostatic hypotension when combined with nitrates 4
Special Populations
Heart Failure with Hypertension
For patients with acute decompensated heart failure and SBP ≥160 mmHg, aggressive IV nitroglycerin is preferred over inotropes in normotensive or hypertensive patients, as inotropes increase ischemic demand and arrhythmia risk 8. High-dose protocols show improved outcomes including lower mechanical ventilation rates and improved survival 6, 7, 8.
Pregnancy
Pregnancy Category C—use only if clearly needed 4
Renal Failure
No dosage adjustment required 4